|
|
|
PROGRAM ON THE PHARMACEUTICAL INDUSTRY
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 
EST. 1991
PROFESSORS THOMAS J. ALLEN, & CHARLES L. COONEY, STAN FINKELSTEIN,
M.D., &
ANTHONY J. SINSKEY, CO-DIRECTORS
http://web.mit.edu/popi/index.html
|
 |
 |
|
|
|
The global pharmaceutical industry
is continuously evolving in the face of advances
in medical science and technology, changing
regulatory requirements, and rapid shifts
in the structure of the health care market.
The MIT Program on the Pharmaceutical Industry
(POPI) collaborates with its industry partners
to investigate the factors that drive, constrain,
and enhance the productivity and competitiveness
|
|
|
of the industry, helping to strengthen and sustain
its success.
|
|
In assessing the productivity
of drug discovery, Center researchers helped build
a financial simulation model that has added to the
industry's understanding of costs, risks, and returns
in successfully developing new drugs. Innovation
and technology transfer research projects include:
the Economic Impact of Pharmacogenomics and Personalized
Medicine, Technology Transfer and the Integration
of Technological Innovation, and The Role of Publicly
Funded Research in Private-Sector Pharmaceutical
Innovation. An in-depth observation-based study
of pharmaceutical manufacturing led to influential
findings on the increasingly important (but heretofore
largely neglected) strategic role that manufacturing
can play in enhancing the competitiveness of firms
in the industry. Research on the pharmaceutical
marketplace has led to important success in quantifying
the quality attributes of cardiovascular, gastrointestinal,
antidepressant, and antihypertensive drugs, and
helped inform the debate over drug prices.
|
|
|
The Center's groundbreaking work in
the area of economic benefits and workplace productivity
first quantified the tremendous adverse economic
impact of untreated mental depression in a study
that was presented at a news conference attended
by Tipper Gore and widely covered in the media.
The Center has also been involved in an evaluation
of the World Health Organization's "Essential
Drug List" of pharmaceutical therapies available
in the developing world.
POPI has recently initiated a detailed
study of the communication and interaction patterns
among firms (large and small) located within the
'Cambridge/Boston Biotech Cluster'. This is the
first study of its kind using actual reports of
communication among scientists with a control group
of firms located outside of the geographic. It will
test the widely held beliefs in the benefits of
geographic clustering of firms.
The Center has offered specialized
executive education to capacity attendance in forums
such as its Summer Professional Programs, Briefings
for Senior Corporate and Technical Management, and
short courses on Management Issues in the Pharmaceutical
and Biotechnology Industry, and Economic and Statistical
Methods in the Assessment of Health Outcomes.
|
|
|
|
|
